AMZNprintsminutestrendsdividendsdrawdownsP/E 28.4macronarrativesvolatilitybuybackssentiment+0.8%marginsMSFTPMI 52.1momentumdividendsflowsPMI 52.1digeststhreadsvolatilityearnings callsvolumesβ 1.24breakoutsnewsflow2s10sliquidityheadlines−1.2%breakoutsnoiseGOOGLbuybacksrevisionstrendsPMI 52.1briefstickersnoiseGDPsentimentchattertranscriptsGOOGLsentimentvolatilitybuybacksMSFTwhispersMETAsessionsyield curves13FfuturesdowngradesPMI 52.1headlinesthe tapeflowsdowngradesfutures+0.8%earnings callstranscriptsclosesgammacatalystsrevisionsvolatilitysentimentchatter+2.41%earnings callssentimentfilingstrends10y 4.21%cyclesbuybackswiresspx 0dtewhisperstickersQ3trendsnewsflowearnings callsWTI 78.2sentimentnoisethreadsrumorsnarrativesFOMCconsensusestimatesmomentumYoY +18%tickersmomentumprintsβ 1.24revisions

momentumheadlines52w hipositioning2s10sfilingstrendsprintstrendsmacrocyclesnoise2s10smacroQ3narrativesheadlinesflowscyclesnarrativesspreadstranscriptsdowngradesupgradeswhisperswhispersminutesthe tapeNDXfuturesminutesyield curves52w hithe tapeFOMCcatalystsbriefsthe tapeNVDAguidancetrends52w hidrawdowns2s10swhispersmomentumdrawdownsbuybacks

PCEliquiditysentimentbreakoutsdowngradesP/E 28.4threadsAAPLSPXvolatilityNDXflowscyclesliquidityestimatesEPS 4.12

FENC · NASDAQ · Biotechnology

Fennec Pharmaceuticals (FENC)

Commercializes PEDMARK for pediatric cisplatin-related hearing-loss protection.

$12.33

At close+0.29 (+2.45%)

Watchlist

Something off on this page? Send us feedback.

Breakdown13F · 13D/G · Form 4

Institutions108 holders · as of Jun 30, 2026 · largest filers plus last quarter's tail	≈ 46.73%	16.39M shares
Insiders8 holders · as of Sep 1, 2026	7.22%	2.53M shares
Strategic holders1 holder · as of Jan 14, 2026	7.83%	2.74M shares
Otherremainder	≈ 38.22%	13.40M shares

35.07M company shares as of Sep 3, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing

This quarter's institutional total failed a plausibility check; shown: the largest filers plus last quarter's remainder.

Top shareholders13F · 13D/G · Form 4

Holder	Stake	Shares	Evidence
Rosalind Advisors, Inc.Institution	9.09%	3.19M	13Fas of Jun 30, 2026
Southpoint Master Fund, LP¹Strategic10 percent owner	7.83%	2.74M	13Gfiled Jan 14, 2026 ↗
Sonic Fund II, L.P.Institution	7.44%	2.61M	13Gfiled Feb 17, 2026 ↗
Aigh Capital Management LLCInstitution	7.09%	2.49M	13Fas of Jun 30, 2026
Orin HirschmanInsider	5.65%	1.98M	13Gfiled Apr 28, 2026 ↗
Solas Capital Management, LLCInstitution	5.39%	1.89M	13Fas of Jun 30, 2026
BlackRock, Inc.Institution	4.93%	1.73M	13Fas of Jun 30, 2026
Awm Investment Company, Inc.Institution	3.31%	1.16M	13Fas of Jun 30, 2026
Vanguard Capital Management LLCInstitution	2.39%	839,306	13Fas of Jun 30, 2026
Prospect Capital Advisors, LLCInstitution	1.42%	497,800	13Fas of Jun 30, 2026
State Street CorpInstitution	1.21%	426,004	13Fas of Jun 30, 2026
Geode Capital Management, LLCInstitution	1.15%	402,566	13Fas of Jun 30, 2026
Robert AndradeInsiderofficer: CHIEF FINANCIAL OFFICER	0.69%	241,306	Form 4filed Aug 31, 2026 ↗
Jane Street Group, LLCInstitution	0.67%	233,877	13Fas of Jun 30, 2026
Potomac Capital Management, Inc.Institution	0.64%	224,400	13Fas of Jun 30, 2026
Morgan StanleyInstitution	0.63%	221,920	13Fas of Jun 30, 2026
Vanguard Portfolio Management LLCInstitution	0.57%	199,998	13Fas of Jun 30, 2026
Northern Trust CorpInstitution	0.48%	167,922	13Fas of Jun 30, 2026
Marshall Wace, LLPInstitution	0.40%	138,758	13Fas of Jun 30, 2026
Renaissance Technologies LLCInstitution	0.38%	134,200	13Fas of Jun 30, 2026
Nuveen, LLCInstitution	0.37%	131,482	13Fas of Jun 30, 2026
Rosty RaykovInsiderother: Former Director	0.35%	124,411	Form 4filed Sep 1, 2026 ↗
Trexquant Investment LPInstitution	0.34%	119,122	13Fas of Jun 30, 2026
Centerbook Partners LPInstitution	0.34%	118,582	13Fas of Jun 30, 2026
Lion Point Capital, LPInstitution	0.32%	112,434	13Fas of Jun 30, 2026

Southpoint Master Fund, LP's own ownership statement (13G, Jan 14, 2026) reports fewer shares than the transaction reports; the statement is used.

13F — a manager's quarterly holdings · 13D/13G — an ownership statement filed at 5% or more · Form 4 — an insider's transaction report

Institutions13F, as of Jun 30, 2026

108 holders · 16.39M shares · 27 new positions · 73 increased · 17 reduced · 10 closed

Holder	Shares	% outstanding	Chg q/q	Filed
Rosalind Advisors, Inc.	3.19M	9.09%	+279.8K	Aug 14, 2026
Aigh Capital Management LLC	2.49M	7.09%	+504.5K	Aug 7, 2026
Solas Capital Management, LLC	1.89M	5.39%	−592.8K	Aug 14, 2026
BlackRock, Inc.	1.73M	4.93%	+358.9K	Aug 7, 2026
Awm Investment Company, Inc.	1.16M	3.31%	+440.2K	Aug 14, 2026
Vanguard Capital Management LLC	839.3K	2.39%	−57.8K	Aug 13, 2026
Prospect Capital Advisors, LLC	497.8K	1.42%	+497.8Knew	Aug 14, 2026
State Street Corp	426.0K	1.21%	+66.9K	Aug 7, 2026

Ownership statements13D/G · 5% or more, as filed

Holder	% of class	Shares	Form	Filed
Rosalind Advisors, Inc.	8.80%	3.04M	13G	May 14, 2026 ↗
Southpoint Master Fund, LP	8.00%	2.74M	13G	Jan 14, 2026 ↗
Sonic Fund II, L.P.	7.60%	2.61M	13G	Feb 17, 2026 ↗
Solas Capital Management, LLC	7.20%	2.48M	13G	May 15, 2026 ↗
Orin Hirschman	5.70%	1.98M	13G	Apr 28, 2026 ↗

Insider tradesForm 4

Latest trades

Date	Insider	Type	Shares	Avg price	Owned after
Sep 1, 2026	Rosty Raykovother: Former Director	Sale	10,000	$12.11	124,411
Aug 31, 2026	Pierre Sargis Sayadofficer: Chief Medical Officer	Sale	12,000	$12.18	9,519
Aug 27, 2026	Robert Andradeofficer: CHIEF FINANCIAL OFFICER	Sale	75,000	$11.78	217,675
Aug 3, 2026	Rosty Raykovother: Former Director	Sale	10,000	$9.58	131,633
Jul 1, 2026	Rosty Raykovother: Former Director	Sale	9,599	$10.41	138,855
Jun 1, 2026	Rosty Raykovdirector	Sale	9,747	$9.62	130,079
May 11, 2026	Chris A. Rallisdirector	Sale	8,346	$7.04	63,077
May 1, 2026	Rosty Raykovdirector	Sale	10,781	$6.47	121,451
Apr 1, 2026	Rosty Raykovdirector	Sale	10,946	$6.31	113,856
Mar 2, 2026	Rosty Raykovdirector	Sale	10,079	$8.36	103,996

CongressHouse and Senate disclosures

Not reported.